Serum levels of helper factors (IL-1α, IL-1β and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and β2-microglobulin in patients with B-CLL and benign B lymphocytosis
- 31 July 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (6-7) , 607-613
- https://doi.org/10.1016/0145-2126(92)90009-v
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Soluble CD4 in patients with rheumatoid arthritis and osteoarthritisClinical Immunology and Immunopathology, 1991
- Interleukin 1: the first interleukinImmunology Today, 1990
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemiaEuropean Journal of Haematology, 1990
- Serum levels of soluble CD8 are increased in patients with B chronic lymphocytic leukemiaEuropean Journal of Cancer and Clinical Oncology, 1989
- Clonal cell surface structures related to differentiation, activation and homing in B‐cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significanceEuropean Journal of Haematology, 1989
- B cell chronic lymphocytic leukaemia: Recent concepts in classification and treatmentEuropean Journal of Haematology, 1989
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- T lymphocyte subpopulations in chronic lymphocytic leukemia of B cell type in relation to immunoglobulin isotype(s) on the leukemic clone and to clinical featuresEuropean Journal of Haematology, 1987